Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms of Parkinson's disease in Amsterdam this week, Amsterdam UMC reported. The ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

Regenerative medicine is an exciting field with a promising future, capable of tackling inherent challenges seen with current therapies.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Stimulating dopamine-producing brain cells wirelessly with gold nanoparticles has proven effective at treating mice with ...